CJC-1295

CJC-1295 is a synthetic peptide analog of growth hormone–releasing hormone (GHRH), developed to study its interaction with pathways involved in growth hormone secretion. It is engineered for enhanced stability and prolonged activity compared to naturally occurring GHRH.

This peptide is commonly referenced in laboratory and research settings exploring endocrine signaling, peptide stability, and growth hormone regulatory mechanisms. Certain variants of CJC-1295 are modified to extend half-life, allowing sustained receptor interaction in experimental models.

Key Characteristics

• Synthetic GHRH analog

• Designed for extended stability

• High receptor specificity

• Supplied in lyophilized (freeze-dried) form

• Intended for laboratory and research use only